Does FOSAPREPITANT Cause Malignant neoplasm progression? 5 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with FOSAPREPITANT. This represents 1.0% of all adverse event reports for FOSAPREPITANT.
5
Reports of Malignant neoplasm progression with FOSAPREPITANT
1.0%
of all FOSAPREPITANT reports
4
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From FOSAPREPITANT?
Of the 5 reports, 4 (80.0%) resulted in death, 5 (100.0%) required hospitalization, and 3 (60.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does FOSAPREPITANT Cause?
Dyspnoea (195)
Infusion related reaction (167)
Hypersensitivity (157)
Duodenal ulcer perforation (155)
Confusional state (149)
Glossodynia (149)
Folliculitis (146)
Arthralgia (144)
Blister (144)
Discomfort (144)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which FOSAPREPITANT Alternatives Have Lower Malignant neoplasm progression Risk?
FOSAPREPITANT vs FOSAPREPITANT DIMEGLUMINE
FOSAPREPITANT vs FOSCARBIDOPA\FOSLEVODOPA
FOSAPREPITANT vs FOSCARNET
FOSAPREPITANT vs FOSFOMYCIN
FOSAPREPITANT vs FOSFOMYCIN TROMETHAMINE